Theralink THER Stock
Theralink Price Chart
Theralink THER Financial and Trading Overview
| Theralink stock price | 0.0001 USD |
| Previous Close | 0.0001 USD |
| Open | 0.001 USD |
| Bid | 0 USD x 0 |
| Ask | 0 USD x 0 |
| Day's Range | 0.001 - 0.001 USD |
| 52 Week Range | 0.0001 - 0.001 USD |
| Volume | 110 USD |
| Avg. Volume | 0 USD |
| Market Cap | 615.15K USD |
| Beta (5Y Monthly) | 57.903 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
THER Valuation Measures
| Enterprise Value | 23.74M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 0.96805257 |
| Price/Book (mrq) | N/A |
| Enterprise Value/Revenue | 37.356 |
| Enterprise Value/EBITDA | -3.162 |
Trading Information
Theralink Stock Price History
| Beta (5Y Monthly) | 57.903 |
| 52-Week Change | 0% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.001 USD |
| 52 Week Low | 0.0001 USD |
| 50-Day Moving Average | 0.0001 USD |
| 200-Day Moving Average | 0.0001 USD |
THER Share Statistics
| Avg. Volume (3 month) | 0 USD |
| Avg. Daily Volume (10-Days) | 0 USD |
| Shares Outstanding | 6.15B |
| Float | 1.07B |
| Short Ratio | N/A |
| % Held by Insiders | 82.61% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:750 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | September 30, 2023 |
| Most Recent Quarter (mrq) | December 31, 2023 |
| Next Fiscal Year End | September 30, 2024 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1842.85% |
| Gross Margin | 61.40% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -191.54% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 635.45K USD |
| Revenue Per Share (ttm) | 0 USD |
| Quarterly Revenue Growth (yoy) | 51.80% |
| Gross Profit (ttm) | 390.2K USD |
| EBITDA | -7507841 USD |
| Net Income Avi to Common (ttm) | -13497796 USD |
| Diluted EPS (ttm) | 0 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 24.27K USD |
| Total Cash Per Share (mrq) | 0 USD |
| Total Debt (mrq) | 23.76M USD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 0.004 |
| Book Value Per Share (mrq) | -0.009 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -4961299 USD |
| Levered Free Cash Flow (ttm) | -8987239 USD |
Profile of Theralink
| Country | United States |
| State | CO |
| City | Golden |
| Address | 15000 West 6th Avenue |
| ZIP | 80401 |
| Phone | 888 585 4923 |
| Website | https://www.theralink.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 16 |
Theralink Technologies, Inc., a commercial-stage precision medicine and molecular data-generating company, engages in the development and commercialization of oncology products in the United States. The company offers patented phosphoprotein and protein biomarker platform, and laboratory developed test technology targets multiple areas of oncology and drug development. It also provides precision oncology data through its Theralink Reverse Phase Protein Array assays to assist the biopharmaceutical industry and clinical oncologists in identifying likely responders and non-responders to FDA-approved and investigational drug treatments. In addition, the company's data-generating assays provide actionable information for physicians, patients, and biopharmaceutical companies in the area of oncology. The company was formerly known as OncBioMune Pharmaceuticals, Inc. and changed its name to Theralink Technologies, Inc. in September 2020. Theralink Technologies, Inc.is headquartered in Golden, Colorado. Theralink Technologies, Inc. is a subsidiary of Theralink Technologies, Inc.
Q&A For Theralink Stock
What is a current THER stock price?
Theralink THER stock price today per share is 0.0001 USD.
How to purchase Theralink stock?
You can buy THER shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Theralink?
The stock symbol or ticker of Theralink is THER.
Which industry does the Theralink company belong to?
The Theralink industry is Biotechnology.
How many shares does Theralink have in circulation?
The max supply of Theralink shares is 6.15B.
What is Theralink Price to Earnings Ratio (PE Ratio)?
Theralink PE Ratio is now.
What was Theralink earnings per share over the trailing 12 months (TTM)?
Theralink EPS is 0 USD over the trailing 12 months.
Which sector does the Theralink company belong to?
The Theralink sector is Healthcare.